Home › Liposarcoma › Florida › Miami
Liposarcoma clinical trials in Miami, FL
4 studies for Liposarcoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Nicklaus Children's Hospital, Miami
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
RecruitingPhase 1/2
- University of Miami-Sylvester Comprehensive Cancer Center, Miami
Liposarcoma trials in other cities
- Houston, TX11 studies
- New York City, NY7 studies
- Boston, MA7 studies
- St. Louis, MO5 studies
- Queens, NY5 studies
- Chicago, IL5 studies
- Nashville, TN4 studies
- Tampa, FL4 studies
- Atlanta, GA4 studies
- Edison, NJ4 studies
- Seattle, WA4 studies
- Gainesville, FL3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.